Who founded Orna Therapeutics Holdings, LLC?

Orna Therapeutics Holdings, LLC was founded by Daniel Anderson, Thomas M. Barnes in 2020.

Who are Orna Therapeutics Holdings, LLC's investors?

Orna Therapeutics Holdings, LLC's investors include Astellas Venture Management LLC, MPM BioImpact.

How much funding has Orna Therapeutics Holdings, LLC raised?

Orna Therapeutics Holdings, LLC has disclosed $120.6M raised across 1 round.

Where is Orna Therapeutics Holdings, LLC headquartered?

Orna Therapeutics Holdings, LLC is headquartered in Cambridge, US.

Orna Therapeutics Holdings, LLC

Cambridge, US · Founded 2020 · 2 known investors

Find your way into Orna Therapeutics Holdings, LLC

142 people in our graph share verified history with the Orna Therapeutics Holdings, LLC team — schools, employers, funds. One of them is your warm intro.

Scott Billerunlockedknows Dan Anderson · together at Foghorn Therapeutics Inc. (overlapped)

×2knows the team · via Northeastern University

×7knows the team · via United States Marine Corps

×2knows the team · via Trinity High School

Circular RNA-based cell engineering

Biotech

Founders & leadership

Orna Therapeutics Holdings, LLC was founded in 2020 by Daniel Anderson and Thomas M. Barnes.

Daniel Anderson inCo-founderDaniel Anderson is Director at Orna Therapeutics Holdings, which develops circular RNA-based cell engineering technology. He has held operations and team leadership roles of increasing scope.

Thomas M. BarnesCo-founder

Robert MarbyExecutive

John McCabeinExecutive

William ShenExecutive

Nishla KeiserExecutive

Board

Brian Goodman inBoard directorPartner at MPM BioImpact

Sakae AsanumaBoard director

Morana Jovan-EmbiricosBoard director

Ansbert Gadicke inBoard directorManaging Partner at MPM BioImpact

Thomas EbelingBoard director

Francesco MarincolaBoard director

Investors · 2

Astellas Venture Management LLCSouth San Francisco · $200K – $5M

MPM BioImpactreportedBoston · $1M – $15Mvia Ansbert K. Gadicke · board

Reported raises · per SEC filings

Form D private placements

$120.6M disclosed across 1 round · 2022

▶$120.6MraisedAug 2022 · 17 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Brian GoodmanDirector
Sakae AsanumaDirector
Daniel AndersonDirector
Robert MarbyExecutive Officer
John McCabeExecutive Officer
William ShenExecutive Officer
Morana Jovan-EmbiricosDirector
Nishla KeiserExecutive Officer
Thomas EbelingDirector
Francesco MarincolaDirector
Ansbert GadickeDirector
Thomas M. BarnesExecutive Officer, Director

Offering amount: $300M
Amount sold: $120.6M
First sale: Aug 2022
Incorporated: Limited Liability Company, Delaware, 2020
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Orna Therapeutics Holdings, LLC do?: Circular RNA-based cell engineering
Who founded Orna Therapeutics Holdings, LLC?: Orna Therapeutics Holdings, LLC was founded by Daniel Anderson, Thomas M. Barnes in 2020.
Who are Orna Therapeutics Holdings, LLC's investors?: Orna Therapeutics Holdings, LLC's investors include Astellas Venture Management LLC, MPM BioImpact.
How much funding has Orna Therapeutics Holdings, LLC raised?: Orna Therapeutics Holdings, LLC has disclosed $120.6M raised across 1 round.
Where is Orna Therapeutics Holdings, LLC headquartered?: Orna Therapeutics Holdings, LLC is headquartered in Cambridge, US.